In doxorubicin-resistant breast cancer cells that have high levels of ABCB5, ERK-3 serine/threonine kinase is specifically upregulated, suggesting that ABCB5 and ERK3 could be potential targets against drug-resistant breast cancer cells [25]. This evidence concerns the gene ABCB5 and breast cancer.